Login

Interview Michel Finance, Director, Theradiag 00:00:00

Share On Facebook Share On Twitter

Interview Michel Finance, Director, Theradiag

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Recent Drilling Results at AMEX Exploration's Perron Project
00:10:00
The Bold women are always investing in bold founders|Kelly Graziadei,Founder and General Partner,f7 Ventures
00:10:00
Robert Ogór on AMBRA SA's Wine Market Strategy and Increased Dividend Expectations | Robert Ogór, President, AMBRA SA.
00:10:00
Fostering Authentic Leadership and Cultivating Next-Generation Leaders | Savneet Singh, CEO, PAR Technology Corp.
00:10:00
Mats Rahmström on Leadership and Corporate Culture at Atlas Copco | In Good Company Podcast by Norges Bank Investment Management
00:10:00
Exploring Success: Lars Ove Løseth's Journey from Alti Centers to Aurora Eiendom|CEO , Aurora Eiendom AS
00:10:00
Navoi Mining: Uzbekistan's Leading Gold Producer and Expansion Plans
00:10:00
planning our future something we can do with presence|Eckhart Tolle,CEO,Conscious Life Design
00:00:00
Harold Burstein, MD, PhD Clinical investigator in the Breast Oncology Center / Professor of Medicine, Harvard Medical School
00:10:00
Explaining Double Trigger RSUs: Key Differences and IPO Impact | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Nordic Nickel: Exploring Finland's Potential in Nickel Sulfides
00:10:00
Key Updates on Concessions, Commodity Impacts, and U.S. Critical Minerals Strategy

© 2026 Nehu